U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07035769) titled 'A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio 1453P in Healthy Adults' on June 16.
Brief Summary: The main purpose of this study is to evaluate the safety, tolerability and pharmacokinetics (PK) of Debio 1453P compared to placebo across different dose levels in healthy adults after single and repeated oral dosing.
Study Start Date: June 18
Study Type: INTERVENTIONAL
Condition:
Healthy Participants
Intervention:
DRUG: Debio 1453P
Powder for oral solution
DRUG: Placebo
Oral solution
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Debiopharm Internati...